Rates of Antidepressant, Anxiolytic, and ADHD Medication Use Among Patients Undergoing ESS.
Alan D WorkmanLillian W DattiloMargaret B MitchellVinay K RathiNeil BhattacharyyaPublished in: The Annals of otology, rhinology, and laryngology (2023)
Patients with chronic rhinosinusitis (CRS) are estimated to have psychiatric comorbidity at a higher rate than the general population; however, self-report of depression diagnoses or symptoms often underestimates true prevalence in many populations. In the present study, a cohort of 2279 patients undergoing endoscopic sinus surgery (ESS) were matched to an equal number of non-CRS control subjects by age, sex, race and health status. Overall, the rate of antidepressant/anxiolytic utilization among ESS patients was 22.1%versus 11.3% for controls ( P < .001, OR = 2.23, 95% CI 1.90-2.63). The rate of ADHD medication utilization among ESS patients was 3.6%versus 2.0% for controls ( P = .001, OR = 1.85, 95% CI 1.28-2.68). This study suggests that patients undergoing ESS exhibit significantly higher rates of antidepressant and ADHD medication utilization relative to a matched control population.
Keyphrases
- patients undergoing
- end stage renal disease
- attention deficit hyperactivity disorder
- major depressive disorder
- newly diagnosed
- ejection fraction
- autism spectrum disorder
- working memory
- healthcare
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- risk factors
- minimally invasive
- depressive symptoms
- physical activity
- bipolar disorder
- emergency department
- patient reported outcomes
- chronic rhinosinusitis
- percutaneous coronary intervention
- electronic health record